Current location: slot bet kecil apk > hitam slot bet > login ph365 > main body

login ph365

2025-01-13 2025 European Cup login ph365 News
Losing weight and having a lean physique is a desire for many, nevertheless, for most, it stays just that — a dream. Have you ever wondered why? Why do some people seem to lose weight effortlessly, while others fight their entire lives? Why don't healthy nutrition and everyday exercise always produce the expected results? If you've heard that it's due to metabolism or a slow metabolic rate, you're half correct. But have you considered why your body's metabolism is sluggish in the first place? Diabetes, thyroid problems, a sedentary lifestyle, stress and other hormonal disorders are common causes of slow metabolism. However, there is a cause that frequently goes unnoticed: low mitochondrial levels. Mitochondria are the cells' energy powerhouses, transforming food into energy. When your mitochondria levels are inadequate, your body's capacity to effectively burn fat suffers, leaving you with obstinate body weight and a slew of other health issues. Is there no solution? Fortunately, nature provides an answer. Enter Mitolyn , a novel nutritional supplement that can target the underlying reason for excess body weight: low mitochondrial levels. Mitolyn has received some notice for its potential to address this hidden element, and user reviews are nothing short of inspiring. Mitolyn's claims of dramatic weight loss and apparent health improvements pique interest. In this in-depth Mitolyn review, you’re going to learn more about its ingredients, possible advantages, and potential to help you figure out if it's the solution you're looking for. Continue reading to uncover more about Mitolyn and its potential. Supplement Description Type: Fat-burning product Total Count: 60 capsules per bottle Produced For: 18+ Men and women with extra body fat Health Advantages: Serving Direction: Swallow 1-2 capsules every day with a full glass of cold water Manufacturing Standards: Cost: $59 onwards ( Official Website ) Refund: 90-day money-back guarantee Mitolyn is more than simply a weight loss pill; it's a groundbreaking composition that can help maximize your body's metabolic capabilities. It goes beyond the typical weight loss promises by addressing a basic factor that is frequently overlooked: the condition of your mitochondria. These microscopic yet important structures are the cells' powerhouses, transforming food into energy. When mitochondrial levels are low, your body struggles to burn calories efficiently, resulting in obstinate weight gain and low levels of energy. Mitolyn distinguishes itself with a distinctive blend of six exotic nutrients and botanicals carefully selected to help promote healthy mitochondrial activity. This one-of-a-kind mixture is based on scientific study, so each ingredient works together to help boost your metabolism and energy levels. Unlike generic supplements, Mitolyn's natural formula emphasizes sustainability and long-term benefits while minimizing the possibility of negative side effects. Mitolyn is made from 100% natural components and plant-based minerals, so it has no GMOs, additives, or dangerous stimulants. It comes in the form of an easy-to-take capsule, making your daily routine more convenient and simple. The formula is non-addictive, so consumers can start and stop without worrying about reliance. Mitolyn is made in an FDA-registered and GMP-certified facility, ensuring adequate levels of quality and safety. This dedication to perfection has made it a popular choice for people seeking long-term weight loss and better overall health. Mitolyn is more than just a supplement; it's a lifestyle update that can allow you to take control of your weight reduction journey and live a better, more active life. Get started with Mitolyn today! Importance Of Healthy Mitochondria Levels Mitochondria, sometimes known as the "powerhouses of the cell," play an important part in maintaining a healthy weight. When their function is disrupted, a series of issues arise, making weight management difficult. One of the most serious concerns associated with damaged mitochondria is the body's inability to burn fat efficiently. Mitochondria turn stored calories and fat into energy. When these tiny structures are damaged, fat oxidation decreases, resulting in persistent weight gain that nutrition and physical activity alone cannot reverse. Low mitochondrial levels also result in lower energy generation, which has a direct impact on physical activity. Individuals with poor mitochondrial health frequently feel fatigued, making it harder to maintain a vigorous routine or engage in regular workouts. This lack of mobility exacerbates weight growth, resulting in an endless cycle. Furthermore, damaged mitochondria cause hormonal abnormalities since they regulate metabolic hormones. Disruptions in these hormones can cause increased hunger, poor satiety, and a tendency to retain fat rather than burn it. Chronic inflammation and oxidative stress are two additional problems linked with mitochondrial dysfunction. These factors not only impede metabolism but also encourage the storage of visceral fat, raising the risk of obesity-related illnesses. Without addressing these underlying causes, maintaining a healthy body weight is extremely impossible. Mitolyn is a science-backed, novel approach to weight loss that targets a primary reason that most fat management treatments overlook: low mitochondrial levels. These little powerhouses within your cells play an important part in your body's capacity to burn fat, generate energy, and maintain overall health. But how does Mitolyn do this? Mitolyn's success is based on its capacity to support and possibly increase the activity of mitochondria. Mitochondria transform the food you ingest into energy, known as ATP. This energy powers everything, from muscular contraction to brain activity. Low mitochondrial levels reduce energy generation, delay fat burning and cause undesirable weight gain. Mitolyn works to rejuvenate these cellular powerhouses, potentially helping your body burn fat more efficiently and produce the energy it requires to survive. Mitolyn is a holistic health supplement that does more than just help you lose weight. It can help promote cholesterol balance and may improve circulation, both of which benefit heart health. The mixture can also improve immune function, allowing your body to fight off infections more efficiently. It may help improve skin, liver and digestive health, possibly resulting in a more vibrant and energetic lifestyle. Chronic stress is a silent impediment to successful weight management. Mitolyn contains substances that may help control stress hormones, boost mood and promote mental clarity. Mitolyn can help promote the smoothest possible weight loss path by addressing both physical and mental well-being. Researchers discovered that decreased mitochondrial levels are a common cause in obese people. Mitolyn builds on this discovery by addressing the cellular basis of energy and fat metabolism. It's a comprehensive program designed to help you accomplish not only weight loss but also total energy and wellness. Click here to check out the official website for Mitolyn >>> Customers who have tried Mitolyn have shared remarkable transformation tales, emphasizing the product's effectiveness in helping them meet their weight loss goals. Some customers report significant weight loss, generally in the 30-40 pound range, which they struggled to attain with traditional approaches. The most frequently claimed effects include increased energy, enhanced metabolism, and greater confidence in their appearance. One common topic in evaluations is the desire to better one's lifestyle. Customers frequently report feeling more active and capable of participating in daily tasks that were earlier laborious. Mitolyn appears to help more than just weight loss — it helps improve general well-being. Many purchasers prefer multi-bottle bundles, particularly the six-bottle option, because they allow for more consistent use and provide better value. This demonstrates users' belief in Mitolyn's capacity to produce long-term outcomes. Some customers even say that Mitolyn re-energized their metabolism after years of stagnation, allowing them to burn stubborn belly fat and break through painful weight plateaus. Overall, consumers feel empowered and driven, with Mitolyn playing a key role in their quest for better health and happiness. Mitolyn is unique in terms of formulation. It is created using plant-based compounds, vitamins, and minerals. After a thorough research and examination, here are some of the main Mitolyn ingredients: Rhodiola is a potent adaptogen known for its potential ability to battle both physical and mental stress, making it a crucial element in Mitolyn. Stress frequently disturbs the body's metabolism, resulting in weight gain and energy depletion. Rhodiola works by improving mitochondrial activity, increasing energy output, and promoting fat metabolism . It also can regulate cortisol levels, which reduces stress-induced cravings and impulsive eating. Rhodiola may also boost endurance and stamina, allowing you to perform better throughout the exercise. This powerful herb keeps your body in peak condition for effective weight management by addressing both mental and physical pressures. Amla, commonly referred to as Indian gooseberry, is a high-antioxidant, vitamin C-rich superfood. This superfruit promotes healthy metabolism by lowering oxidative stress in mitochondria, allowing them to function more efficiently. Amla improves digestion and detoxification, which are essential for a healthy weight. Its anti-inflammatory qualities contribute to the reduction of chronic inflammation, which is frequently associated with persistent fat storage. Furthermore, Amla promotes greater absorption of nutrients, ensuring that your body receives the necessary components for energy production. Amla is an important ingredient in Mitolyn's weight loss recipe because of its capacity to potentially enhance metabolic health as well as cell function. Schisandra is a multi-purpose herb that promotes mitochondrial health by increasing energy output and decreasing weariness. It is well-known for its adaptogenic characteristics, which aid in the body's ability to cope with stress, a typical obstacle to weight loss. Schisandra also improves liver function by assisting in the detoxification processes required for proper metabolism. Its strong antioxidant concentration prevents oxidative stress and maintains mitochondrial integrity. Furthermore, Schisandra regulates blood sugar levels, lowering cravings and encouraging consistent energy. This substance keeps your body energized and concentrated during your weight-loss journey. Get Mitolyn now while it's on sale - limited time only! Maqui Berry contains a high concentration of antioxidants, especially anthocyanins, which shield mitochondria from oxidative stress. This superfruit improves fat metabolism by promoting healthy production of energy at the cellular level . Maqui Berry's anti-inflammatory characteristics also help to promote healthy metabolism, lowering the danger of fat storage caused by chronic inflammation. Furthermore, its capacity to regulate blood sugar levels reduces spikes and crashes, which aids in the control of appetite and cravings. Maqui Berry, with its numerous metabolic benefits, is an important component of Mitolyn's composition. Haematococcus is best recognized for its high levels of astaxanthin, a powerful antioxidant that promotes mitochondrial function. Astaxanthin protects mitochondria from oxidative damage , resulting in maximum energy generation and fat-burning capacity. This component also improves cardiovascular health by supporting healthy blood flow, which is required for nutrient delivery and waste disposal at the cellular level. Haematococcus decreases inflammation, which is a major contributor to metabolic slowing and weight gain. Its unique capacity to increase cellular energy makes it an essential component of Mitolyn, helping to promote efficient fat metabolism and general health. Theobroma cacao, sometimes known as the "food of the gods," is an organic source of flavonoids and magnesium, each of which improves mitochondrial function. It stimulates energy generation by boosting blood flow to cells, ensuring that mitochondria receive vital nutrients. Theobroma Cacao also offers mood-enhancing qualities , lowering stress and preventing emotional eating. Its ability to regulate blood sugar levels reduces insulin surges that cause fat storage. Theobroma Cacao enhances Mitolyn's weight management strategy by promoting metabolic health as well as emotional well-being. Mitolyn is a low-cost weight loss supplement that can help anyone battling with excess fat. To ensure quality and genuineness, the manufacturers offer it exclusively through the official website . This removes intermediaries, lowers costs and prevents phony goods from reaching the market. Customers who purchase directly receive real Mitolyn with guaranteed quality, safe payment options, and exclusive savings and multi-bottle bundles for long-term benefits. Let’s understand its pricing structure: Mitolyn provides adjustable packages to meet various demands and weight loss goals. The single-bottle option is suitable for first-time users who want to evaluate the supplement's efficacy. For those looking for constant progress and visible results, the three-bottle box is an excellent choice since it delivers enough supplies to see consistent benefits. However, for strong, long-term results and the best value, the six-bottle bundle is highly recommended. This option is ideal for people who are determined to lose significant weight and maintain a healthy lifestyle over time. All packages offer complimentary bonuses, which increase the overall worth of the purchase. By selecting a multi-bottle package, consumers ensure continuous use, increasing their chances of achieving long-term health and weight transformation. 100% Satisfaction Guarantee Mitolyn has a 100% satisfaction promise and a 90-day money-back guarantee, allowing users peace of mind to try it risk-free. This policy enables individuals to test Mitolyn's efficacy without incurring financial costs. If users are dissatisfied with the outcomes, they may request a full refund within 90 days after purchase. Customers can simply contact the support team by emailing Contact@mitolyn.com or calling 1800-390-6035. This simple approach assures that everyone can enjoy Mitolyn's benefits with total confidence, making it a trustworthy and customer-focused weight loss option. You won't find a better deal on Mitolyn anywhere else! Free Bonuses With Mitolyn Fat Burner When users purchase three or six bottles of Mitolyn, they get free access to their bonus items. These are eBooks worth $100+, but you get them for free with Mitolyn. Here are these eBooks are about: The 1-Day Kickstart Detox is a strong guide that will reset your body and prepare it for successful weight loss. This ebook, packed with simple recipes and natural detox strategies, will help you remove toxins, minimize bloating, and raise your energy levels in just 24 hours. It works well with Mitolyn, ensuring that your body is in optimal condition to get the benefits of the supplement. Whether you're just starting out on your weight loss journey or need a quick boost, this detox regimen can revive your system and put you on track for success. Renew You is an inspirational ebook that focuses on improving your mental and emotional health while you lose weight. It provides practical ways for coping with stress, improving mood, and developing an optimistic mindset, addressing the often-overlooked psychological obstacles to accomplishing fitness goals. This book supports Mitolyn by providing ideas on mindfulness, self-care routines, and stress management to keep you motivated and balanced. Renew You helps you not only alter your body but also develop your confidence and mental toughness, resulting in a comprehensive approach to long-term health and well-being. Mitolyn provides a different perspective on weight loss, focusing on mitochondria to help your body reach its full potential. It's more than just a quick fix; it's a tool for individuals who want to adopt a long-term commitment to health and fitness. While it can potentially produce great effects for many people, it is critical to control expectations and recognize that it works best when combined with regularity and a healthy lifestyle. Mitolyn is designed for people who want to invest in their long-term health rather than take shortcuts. If you're weary of irritating weight loss plateaus and need a scientifically proven boost, Mitolyn could be the game changer you've been looking for. (LIMITED STOCK) Click Here to Buy Mitolyn at a Special Discounted Price Today! Get local news delivered to your inbox!login ph365

(Updates to afternoon trading) * Latin American currencies up 0.4% on the week, stocks down 0.2% * Brazil's economic activity up 0.1% in October * Peru's central bank sees economy growing over 3% in 2024 By Pranav Kashyap, Johann M Cherian Dec 13 (Reuters) - Most Latin American currencies were poised to log modest gains this week, with Brazil's real on track for its first weekly rise in a month and Peru's sol edging up after the country's central bank left interest rates unchanged. Brazil's real weakened by 0.8% on the day as markets priced in the likelihood that the country would not be able to balance its public accounts this year. However, the currency was set for a weekly rise of 0.7%, after Brazil's central bank hiked interest rates by an unexpected 100 basis points earlier in the week as it tries to combat inflation that analysts say is a result of excessive public spending. Banks in Latin America's largest economy are now predicting the peak interest rate to hit levels not seen in nearly two decades, eyeing the benchmark Selic rate to reach 14.25% by March. It is currently set at 12.25% "We're still exposed to headline risk ... one of the theories surrounding the whole picture is a loss of credibility in institutions, which is relevant when Lula is president, because he likes to bend the rules," said Eduardo Ordonez Bueso, an emerging markets debt portfolio manager at BankInvest. The Brazilian government's efforts to push through a package of spending cuts and tax reforms has kept financial markets on edge. President Luiz Inacio Lula da Silva had been negotiating directly with lawmakers until he was rushed into a hospital in Sao Paulo where he had two operations this week to relieve and prevent bleeding in his skull. Brazil's economy, however, grew in October, defying expectations of a downturn. The currencies of oil exporters Mexico and Colombia edged up 0.4% and 0.6%, respectively, tracking higher crude prices. Both the currencies were also on track to end the week higher. Peru's central bank maintained its benchmark interest rate at 5%, aligning it with market expectations and pushing the sol 0.2% higher. However, stocks slid 1%. The sol has declined the least this year, relative to its peers. The Peruvian central bank's policy rate is among the lowest in Latin America, with future adjustments hinging on inflation trends. Separately, Peru's central bank said the country's economy will likely expand this year by more than 3%. Latin American currencies overall have made modest headway this week, with the currencies index set to snap a four-week slump, thanks to a slightly weaker U.S. dollar. "We're in a holding pattern, maybe a little bit of a Christmas rally, but all the attention, will come back in January when the inauguration of Donald Trump takes place," Bueso added. On the equities front, the stocks index dipped 0.4%, weighed down by a 0.5% drop in Brazil's Bovespa index. Mexico's main stock index climbed 0.3%, while Argentina's Merval index gained more than 2.4% as investors cheered signs of cooling inflation in the economy. Key Latin American stock indexes and currencies: Latin American market prices from Reuters MSCI Emerging Markets 1106.99 -0.53 MSCI LatAm 1997.22 -0.46 Brazil Bovespa 125379.59 -0.53 Mexico IPC 51433.82 0.29 Chile IPSA 6784.85 0.06 Argentina Merval 2360987.3 2.469 Colombia COLCAP 1380.96 -0.3 Brazil real 6.0421 -0.84 Mexico peso 20.116 0.45 Chile peso 985.95 -0.88 Colombia peso 4314.67 0.64 Peru sol 3.728 0.24 Argentina peso (interbank) 1018 0.05 Argentina peso (parallel) 1085 0.91 (Reporting by Pranav Kashyap and Johann M Cherian in Bengaluru; Editing by Alistair Bell and Paul Simao)Meta Platforms Inc. stock underperforms Friday when compared to competitors

Stock market today: Wall Street slips at the end of a bumpy weekHome | EFF blames poor policies for economic crisis, infrastructure collapse The Economic Freedom Fighters (EFF) has called for a commission of inquiry into load-shedding, with party leader Julius Malema alleging economic sabotage when there were attempts to shut down coal-fired power stations. Speaking at the EFF’s Elective Conference in Johannesburg on Friday, Malema emphasises the need for a state-led policy to expand Eskom’s generation capacity, reverse its privatisation, and invest in building more coal-fired power stations. ‘Collapsing infrastructure’ Malema has blamed poor policy choices for South Africa’s ongoing economic crisis. He cites challenges such as low economic growth, the electricity crisis, failing logistics, and collapsing infrastructure. The EFF leader argues that weak policies over the past 15 years have led to stagnant growth, high unemployment—particularly among women and youth—and a decline in public investment, resulting in the breakdown of critical services and the economy. “In the past 15 years, we have witnessed a 24% decline in public investment by the central government and public corporations. This decline in public investment has directly contributed to the collapse of the country’s infrastructure, critical services and economy. It is the decline that has led to the collapse of electricity generation capacity, the collapse of logistics and transport networks, the collapse of water infrastructure, the collapse of telecommunications services.” The EFF says while it’s happy with the current management at Eskom turning the institution around, it remains concerned about the energy policy direction of the country. “We call on a commission of inquiry into the load shedding that our people were subjected to for more than a decade while people were stealing money by burning oil and benefitting from IPPs. We need to know who the culprits were behind the economic sabotage,” Malema adds. The EFF says the country experienced economic sabotage when there was an attempt to close down power stations under the notion that their lifespan was ending. EFF Elective Conference – EFF calls for inquiry into load shedding: SABC © 2024Super Micro Computer Inc. Announces Receipt of Extension from Nasdaq Stock Market - Business Wire

After multiple delays, Kraven the Hunter finally races into theaters this weekend. Unfortunately for this big-game hunter, it will likely be his only appearance on the big screen as Sony bids goodbye to its polarizing Spider-Man Universe. The early box office estimates are not looking good, meaning Kraven might be heading to VOD by the beginning of the new year. If Kraven isn’t your cup of tea, you can find something for free on a FAST service. These free ad-supported services continue to stockpile thousands of high-quality movies. Below are three Oscar-winning movies with no business being offered for free. Thank you, FAST services, for gifting cinephiles with endless content. We also have guides to the best new movies to stream, the best movies on Netflix , the best movies on Hulu , the best movies on Amazon Prime Video , the best movies on Max , and the best movies on Disney+ . The Departed (2006) The movie that finally delivered Martin Scorsese’s long-awaited Oscar was The Departed . Based on Hong Kong’s 2002 film Infernal Affairs , The Departed is a crime drama set in Boston that blurs the lines between the police and the criminals. Boston cop Billy Costigan (Leonardo DiCaprio) goes undercover and works for local crime lord Frank Costello (Jack Nicholson). Costigan’s job is to infiltrate Costello’s organization and find a mole with ties to the police department. Costigan has no idea the mole is Colin Sullivan (Matt Damon), a cop who reports to Costello. The cat-and-mouse thriller becomes a high-wire act for Costello and Sullivan, who know they’re dead if their secrets are revealed. Scorsese blurs the line between good and evil in this frenetic mob thriller that never lets the audience catch their breath. Stream The Departed f or free on Tubi . The Social Network (2010) Every person involved in The Social Network is operating at the highest level. David Fincher’s direction, Aaron Sorkin’s script, Jesse Eisenberg and Andrew Garfield’s performances, Trent Reznor and Atticus Ross’ score, etc. All are worthy of awards, with Sorkin, Reznor, and Ross winning Oscars. The invigorating drama traces the origins of Facebook , which started at Harvard University in the early 2000s. After working on a Harvard-based social networking site, tech genius Mark Zuckerberg (Eisenberg) abandons the project to create his own social network, Facebook. The popular site makes Zuckerberg a billionaire, but it also leads to lawsuits, including one from his best friend and co-founder Eduardo Saverin (Garfield). For a movie about men talking in rooms, The Social Network’s drama raises your pulse like it’s the ninth inning of Game 7 of the World Series. Stream The Social Network for free on Pluto TV . Titanic (1997) Before rubbing elbows with Boston’s criminal underbelly in The Departed , Leo was winning the hearts of every girl in Titanic , James Cameron’s Academy Award-winning epic. Inspired by the sinking of the titular ship in 1912, the fictionalized story about star-crossed lovers Jack (DiCaprio) and Rose (Kate Winslet) will make you laugh, cry, and everything in between. Rose is a debutante moving to America to marry the wealthy Cal Hockley (Billy Zane). Jack is a penniless artist who won a third-class ticket in a last-minute poker game. After Jack saves Rose from a suicide attempt, the pair quickly fall in love. Yet a giant iceberg had other plans, derailing their happily-ever-after ending by turning the voyage into a fight for survival. Nearly 30 years later, Titanic remains a technical marvel backed by two life-changing performances from DiCaprio and Winslet. Stream Titanic for free on Pluto TV .No. 7 Tennessee gives up 1st 14 points before rallying to rout Vanderbilt 36-23

Investor confidence was still recovering from recent stock market manipulations when a high-profile investment scam involving Dr Boon Vanasin, an 86-year-old hospital veteran, sent shockwaves throughout Thailand's business arena, causing damages of nearly 8 billion baht. Dr Boon, founder and former chairman of SET-listed Thonburi Healthcare Group (THG), became headline news after being accused of embezzling a massive amount of money through medical investment projects as a means to deceive the public. Police revealed that between December 2023 and October this year, 247 complaints were lodged against him at the Huai Khwang police station by victims who could not cash checks he issued. Dr Boon has fled the country, reportedly to China, while police have charged him and eight others on several counts, with damages initially estimated 7.5 billion baht. The suspects are accused of misleading people into investing in medical businesses promoted by Dr Boon, which police said did not exist. WHO IS DR BOON AND HOW DID HE BUILD HIS HOSPITAL EMPIRE? Dr Boon and his 79-year-old wife come from a prominent family. The doctor established THG in 1977 and continually expanded the business, making him well-known in medical and investment circles. Dr Boon earned the trust of his victims and the public after successfully listing the business on the Stock Exchange of Thailand (SET) in 2017. He was often quoted in news and regularly addressed public events. THG operates seven hospitals in Thailand and two overseas. According to the company's website, the group has 1,100 registered beds and a combined capacity to service 9,700 outpatients daily, making the group one of the leading healthcare providers in Thailand. Dr Boon was keen to articulate the narrative of Thailand becoming an aged society, with the global trend opening a vast opportunity for healthcare and well-being services and residences for senior clients. His standing enabled him to convince many investors to back his proposed projects. Dr Boon envisioned projects such as a cancer centre and a wellness centre in Bangkok, a condo on the banks of the Chao Phraya River for seniors, hospitals in Laos and Vietnam, and a medical intelligence project in Chon Buri province. According to police, the fraud was not the work of a single individual, but involves a network that includes family members and brokers who collaborated in the scheme. HOW WAS THE FRAUD EXECUTED? Dr Boon and his associates leveraged their social status and reputation in the medical business to persuade investors to join seemingly credible projects. He offered loan agreements with attractive interest rates to investors, issuing post-dated checks to cover principal and interest payments. However, these checks could not be cashed, leaving investors without the returns they were promised. Initially, Dr Boon paid the loan interest as promised to build confidence among investors. However, when the larger payments were due, he failed to do so, resulting in massive financial losses for investors. Finance permanent secretary Lavaron Sangsnit, who is also a board member of the Securities and Exchange Commission (SEC), said Dr Boon engaged in off-market fundraising by inviting lenders to invest, offering attractive interest rates and claiming the borrowed funds would be invested in various projects. To secure these loans, Dr Boon used shares of Thonburi Hospital, where he was a major shareholder, as collateral. For example, for a loan of 100 baht, he pledged 4 shares of Thonburi Hospital, which were valued at 25 baht per share at the time. As the hospital's share price increased, the number of shares required as collateral decreased proportionally. According to the SET, Dr Boon is the 17th-largest shareholder in THG, holding 5.8 million shares, equivalent to 0.68% of the company, valued at 90 million baht. Victims reported that Dr Boon and his family offered high-return investments with advance interest payments. However, when the principal and interest came due in 2023, there were payment problems, and many checks issued to investors could not be cashed, leading to widespread complaints to the authorities. WHO ARE THE VICTIMS? According to the police, there are several groups of victims, including private lenders who demanded off-market shares as collateral. These lenders provided loans to Dr Boon in exchange for high interest rates of 8-9%. They did not receive repayments as promised in agreements, and many were forced to sell their debts at a discount to minimise losses. Another group comprises major investors in the capital market, including business executives and wealthy individuals who invested in THG shares or projects that were non-existent. Other victims include medical industry leaders, such as doctors managing Thonburi hospitals. They were reportedly lured into investing tens of millions of baht in these projects. Also ensnared were business tycoons and members from high-profile families, including political families, as some shifted into business ventures and were encouraged to invest, according to the police. In addition, the owners of construction materials, telecom and real estate firms were listed as victims, lending significant sums to Dr Boon, noted the authorities. The final group of victims is retail investors, including THG shareholders. Retail shareholders who trusted the company and invested in THG shares suffered indirect losses from the financial damage and reputational harm caused by the scandal. The scandal also shook confidence in the already fragile Thai capital market, particularly regarding transactions involving off-market shares and the use of assets as collateral. WHAT IS THE EXTENT OF THE DAMAGES? The initial damages claimed in lawsuits are estimated at 7.5 billion baht. However, total damages are estimated to reach 20-40 billion baht. The number of victims is currently 500-600 people, with more expected as investigations progress. There is speculation Dr Boon used his personal THG shares as collateral to secure loans amounting to roughly 2 billion baht. This may have been linked to his financial liquidity issues, possibly arising from unsuccessful large-scale investments. It is believed he sought additional funds to stabilise his personal finances. However, Dr Boon denied these allegations, asserting that no such pledging of shares took place. General investors are concerned because the activities involving THG shares led to questions about the company's financial stability. Stock prices have been volatile as investors want to know about past transactions, investments, and the allocation of funds for large projects that have yet to yield clear returns. HOW ARE THE INVESTIGATIONS PROGRESSING? THG's board of directors has initiated a thorough investigation into Dr Boon's past transactions and management practices, aiming to restore investor confidence and stabilise the company's future regarding large-scale projects and the management of working capital. Authorities said this case serves as a critical example of the risks associated with using personal assets to manage organisational finances, potentially impacting shareholders and investors on a broad scale. The police issued arrest warrants for two more individuals linked to Dr Boon's network, charging conspiracy to commit fraud and soliciting fraudulent loans from the public. The warrants were issued after victims revealed new evidence that both individuals acted as brokers or intermediaries, encouraging others to invest in the fraudulent schemes. In addition, an arrest warrant was issued for Nawara Vanasin, Dr Boon's former daughter-in-law who previously claimed her signature was forged. However, an investigation into her financial transactions revealed links to Dr Boon. Authorities are examining the authenticity of her signature. Dr Boon's network involved three main groups: Dr Boon and his family; company employees and document witnesses; and brokers or intermediaries. The police emphasised that any further implicated individuals will face legal action without exception. According to Mr Lavaron, the SEC is drafting regulations to control the behaviour of major shareholders in the market, aiming to prevent similar incidents. "To protect minor shareholders in the market, the SEC is preparing a draft regulation to control the actions of major shareholders if they intend to use their shares as collateral for loans, as in the case of Dr Boon," he said. Major shareholders will be required to notify the SET, which will allow authorities to monitor whether such actions might affect other shareholders. The measure is meant to enhance transparency for investors, said Mr Lavaron.

Video: Texas Tech HC Joey McGuire Slams 'Embarrassing' CFP Committee, Defends Big 12

Quest Partners LLC Invests $588,000 in TriCo Bancshares (NASDAQ:TCBK)

The chancellor of the Australian National University, Julie Bishop, has made a strong defence of ANU vice-chancellor Genevieve Bell's role with Intel Corporation. Subscribe now for unlimited access . Login or signup to continue reading All articles from our website & app The digital version of Today's Paper Breaking news alerts direct to your inbox Interactive Crosswords, Sudoku and Trivia All articles from the other regional websites in your area Continue The main union at the ANU had said there was a potential conflict of interest because Professor Bell was a vice-president and a senior fellow at Intel Corporation. She severed the link in November. In September, Intel won a US$3.5 billion (A$5.6 billion) contract to manufacture computer chips for the US military. "The involvement of ANU's vice-chancellor with Intel thus raises significant questions around potential implications under Australia's tight laws on foreign interference and defence security," a letter signed by the leadership of the National Tertiary Education Union to Education Minister Jason Clare said. But the ANU chancellor has written to the university's governing council saying the links with the American corporation were well-known - and, indeed, an asset for the university. "We considered her ongoing association would continue to enhance her international profile and networks for the benefit of ANU," Ms Bishop wrote to her fellow ANU council members. "I was, and remain satisfied, that it was appropriate for the vice-chancellor to maintain her association with Intel, given the limited nature of the role, the due diligence I had undertaken on behalf of the council, and her ongoing commitment to abide by the disclosure requirements." But the Australian Financial Review reported last week that members of the ANU's "governing body say they have no recollection of an agreement for new vice-chancellor Genevieve Bell to continue working for global technology company Intel ever being mentioned". Ms Bishop said in her letter to the ANU council that the committee that appointed Professor Bell to the vice-chancellorship was aware of the Intel link. "Professor Bell's role at Intel was disclosed in detail to that committee, was prominent in her CV, her written application and the candidate report, and was discussed during her presentations to the committee." Vice-chancellor Genevieve Bell, left, and chancellor Julie Bishop. Pictures by Gary Ramage, Sitthixay Ditthaovng The role of chancellor and vice-chancellor of universities, including the ANU, is often likened to that of the chairperson of a company board and the chief executive. They are equals who work in tandem. Both have been embattled recently as the ANU tries to get its deficit of spending over income down, including through making staff redundant . Professor Bell took a 10 per cent cut to her salary of just over $1 million dollars as part of the measures to reduce ANU's ongoing costs by $250 million by early 2026. But a plea to staff to forego a pay-rise was rejected by the staff. Ms Bishop, a former federal Liberal minister, was criticised for the blunt way she portrayed the cuts as staff prepared to vote. Some at the university thought her response hardened staff attitudes. She was asked by The Canberra Times if it was fair of the university to ask staff to give up their pay rises when they believed they had not caused its financial problems. "It depends to whom you refer," Ms Bishop replied, "because many members of staff have been part of the inefficiencies that the university is now seeking to address." On Tuesday last week, a group of ANU alumni wrote to the Australian National Audit Office , stating it had "extensively consulted with ANU alumni and staff". "In view of the crisis engulfing the ANU, we request, that as a matter of urgency, the Australian National Audit Office undertake a financial audit and an audit of the governance of the ANU," the letter said. Share Facebook Twitter Whatsapp Email Copy Steve Evans Reporter Steve Evans is a reporter on The Canberra Times. He's been a BBC correspondent in New York, London, Berlin and Seoul and the sole reporter/photographer/paper deliverer on The Glen Innes Examiner in country New South Wales. "All the jobs have been fascinating - and so it continues." Steve Evans is a reporter on The Canberra Times. He's been a BBC correspondent in New York, London, Berlin and Seoul and the sole reporter/photographer/paper deliverer on The Glen Innes Examiner in country New South Wales. "All the jobs have been fascinating - and so it continues." More from Canberra Forget the stink: why you should just eat the bugs in your backyard 9m ago No comment s 'Refuse to be that player': Kyrgios bullish on eve of his comeback tournament 9m ago No comment s Bishop defends ANU vice-chancellor's 'appropriate' links with Intel Corporation 9m ago Konstas to debut at MCG, Head not certain to play Government considering new penalties for dodgy legal claims after PwC saga No comment s Person with infectious measles stopped off at a Riverina service station Newsletters & Alerts View all DAILY Your morning news Today's top stories curated by our news team. Also includes evening update. Loading... WEEKDAYS The lunch break Grab a quick bite of today's latest news from around the region and the nation. Loading... DAILY Sport The latest news, results & expert analysis. Loading... WEEKDAYS The evening wrap Catch up on the news of the day and unwind with great reading for your evening. Loading... WEEKLY Note from the Editor Get the editor's insights: what's happening & why it matters. Loading... WEEKLY FootyHQ Love footy? We've got all the action covered. Loading... DAILY Early Look At David Pope Your exclusive preview of David Pope's latest cartoon. Loading... AS IT HAPPENS Public Service News Don't miss updates on news about the Public Service. Loading... WEEKLY Explore Travel Every Saturday and Tuesday, explore destinations deals, tips & travel writing to transport you around the globe. Loading... WEEKLY Property Get the latest property and development news here. Loading... WEEKLY What's On Going out or staying in? Find out what's on. Loading... WEEKLY Weekend Reads We've selected the best reading for your weekend. Loading... WEEKLY Times Reader's Panel Join our weekly poll for Canberra Times readers. Loading... WEEKDAYS The Echidna Sharp. Close to the ground. Digging deep. Your weekday morning newsletter on national affairs, politics and more. Loading... TWICE WEEKLY The Informer Your essential national news digest: all the big issues on Wednesday and great reading every Saturday. Loading... WEEKLY Motoring Get news, reviews and expert insights every Thursday from CarExpert, ACM's exclusive motoring partner. Loading... TWICE WEEKLY Voice of Real Australia Get real, Australia! Let the ACM network's editors and journalists bring you news and views from all over. Loading... AS IT HAPPENS Breaking news alert Be the first to know when news breaks. Loading... DAILY Today's Paper Alert Your digital replica of Today's Paper. Ready to read from 5am! Loading... DAILY Your favourite puzzles Test your skills with interactive crosswords, sudoku & trivia. Fresh daily! Loading...No. 24 Louisville women use 16-0 4th-quarter run to beat Colorado 79-71

A Member of the UAE Royal Family Joins the Color Star FamilyMicroSectors U.S. Big Oil Index 3x Leveraged ETN ( NYSEARCA:NRGU – Get Free Report ) traded up 0.1% during trading on Friday . The company traded as high as $503.00 and last traded at $502.48. 26,900 shares traded hands during mid-day trading, a decline of 24% from the average session volume of 35,455 shares. The stock had previously closed at $501.92. MicroSectors U.S. Big Oil Index 3x Leveraged ETN Trading Up 0.1 % The firm has a 50-day simple moving average of $502.48 and a two-hundred day simple moving average of $502.57. The company has a market capitalization of $366.43 billion and a price-to-earnings ratio of 8.72. Institutional Trading of MicroSectors U.S. Big Oil Index 3x Leveraged ETN A hedge fund recently bought a new stake in MicroSectors U.S. Big Oil Index 3x Leveraged ETN stock. Pathway Financial Advisers LLC purchased a new position in shares of MicroSectors U.S. Big Oil Index 3x Leveraged ETN ( NYSEARCA:NRGU – Free Report ) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 132 shares of the company’s stock, valued at approximately $81,000. About MicroSectors U.S. Big Oil Index 3x Leveraged ETN at bmo, banking is our personal commitment to helping people at every stage of their financial lives. the truth is, people’s needs change: so we change too. but we never change who we are. which means we’ll never waiver from providing our customers the best possible banking experience in the industry. See Also Receive News & Ratings for MicroSectors U.S. Big Oil Index 3x Leveraged ETN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MicroSectors U.S. Big Oil Index 3x Leveraged ETN and related companies with MarketBeat.com's FREE daily email newsletter .

Natixis Advisors LLC increased its holdings in Insperity, Inc. ( NYSE:NSP – Free Report ) by 27.4% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 65,016 shares of the business services provider’s stock after buying an additional 13,981 shares during the period. Natixis Advisors LLC owned 0.17% of Insperity worth $5,721,000 as of its most recent SEC filing. Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Insperity by 4.9% during the first quarter. Vanguard Group Inc. now owns 3,911,104 shares of the business services provider’s stock worth $428,696,000 after purchasing an additional 182,773 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Insperity by 3.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 422,163 shares of the business services provider’s stock valued at $38,505,000 after buying an additional 14,095 shares in the last quarter. Renaissance Technologies LLC bought a new stake in shares of Insperity during the 2nd quarter worth $5,536,000. Markel Group Inc. grew its position in Insperity by 32.6% in the third quarter. Markel Group Inc. now owns 70,143 shares of the business services provider’s stock worth $6,173,000 after acquiring an additional 17,237 shares in the last quarter. Finally, Harbor Capital Advisors Inc. increased its stake in Insperity by 69.9% in the third quarter. Harbor Capital Advisors Inc. now owns 105,952 shares of the business services provider’s stock valued at $9,324,000 after acquiring an additional 43,597 shares during the last quarter. Institutional investors own 93.44% of the company’s stock. Analysts Set New Price Targets Several equities research analysts have issued reports on the company. StockNews.com lowered Insperity from a “buy” rating to a “hold” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. began coverage on shares of Insperity in a research report on Tuesday, October 22nd. They set an “underweight” rating and a $90.00 price target on the stock. Truist Financial decreased their price target on shares of Insperity from $95.00 to $88.00 and set a “hold” rating on the stock in a research note on Friday, November 1st. Finally, William Blair cut shares of Insperity from an “outperform” rating to a “market perform” rating in a research note on Tuesday, September 24th. One research analyst has rated the stock with a sell rating and four have assigned a hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $95.67. Insperity Trading Up 3.0 % Shares of NSP stock opened at $76.06 on Friday. The company has a debt-to-equity ratio of 2.95, a current ratio of 1.16 and a quick ratio of 1.16. The business has a 50-day moving average of $83.54 and a 200 day moving average of $91.27. The stock has a market capitalization of $2.84 billion, a PE ratio of 24.15, a P/E/G ratio of 2.04 and a beta of 1.12. Insperity, Inc. has a 1-year low of $71.69 and a 1-year high of $119.40. Insperity Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 24th. Investors of record on Tuesday, December 10th will be issued a dividend of $0.60 per share. The ex-dividend date is Tuesday, December 10th. This represents a $2.40 dividend on an annualized basis and a yield of 3.16%. Insperity’s dividend payout ratio is currently 76.19%. Insperity Company Profile ( Free Report ) Insperity, Inc engages in the provision of human resources (HR) and business solutions to improve business performance for small and medium-sized businesses primarily in the United States. It offers its HR services through its workforce optimization and workforce synchronization solutions that include a range of human resources functions, such as payroll and employment administration, employee benefits, workers' compensation, government compliance, performance management, and training and development services. Read More Want to see what other hedge funds are holding NSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Insperity, Inc. ( NYSE:NSP – Free Report ). Receive News & Ratings for Insperity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Insperity and related companies with MarketBeat.com's FREE daily email newsletter .Green Bay Packers quarterback Jordan Love almost got tricked into paying a massive tab for a total stranger at a barNo. 10 Georgia scores nearly at will, destroys UMass

European Cup News

European Cup video analysis

  • wild rose casino jefferson iowa
  • how to win in jili super ace
  • slot machine animation
  • rich9 ph client login
  • gstar28 app
  • slot machine animation